Coronavirus, discovered test that identifies positives before they show symptoms



[ad_1]

Scientists who work for the US Army. USA They have designed a new Covid-19 test that could identify carriers before they catch and spread the disease, reveals The Guardian.

Coronavirus, emergency income of 400 to 800 euros, these are the requirements

Viruses, all doubts about the Immuni application: the government will have to clarify

IN DEEP

#correlati article figure .player_clicker :: after {color:#fff;background color: rgba (0,0,0,0.6);edge radius: 50%;screen:block;align text: center;font size: 16px;line height: 40 px;width:40px;position:absolute;above:50%;left:50%;margin:-20px 0 0 -21px}#correlati article figure .player_foto_clicker :: after {color:#fff;background color: rgba (0,0,0,0.6);edge radius: 50%;screen:block;align text: center;font size: 20px;line height: 40 px;width:40px;position:absolute;above:50%;left:50%;margin:-20px 0 0 -21px}

->

At what could be a significant turning point, project coordinators hope that blood tests can detect the presence of the virus 24 hours after infection, before people show symptoms and several days before a positive result. he considers himself capable of spreading it to other people. If the EUA is granted, the test is expected to begin implementation in the United States in the second half of May.

Approval is not guaranteed, but Darpa scientists are delighted with the potential impact as governments ease the blockages between concerns about controlling possible second wave outbreaks. The test came from a project instituted by the US Army’s Defense Advanced Research Projects Agency (Darpa). USA Aimed at rapid diagnosis of germ poisoning or chemical warfare. It was quickly revived when the pandemic broke out and the new test is expected to be submitted for emergency approval (USA) by the US Food and Drug Administration (FDA) within a week. “The concept fills a diagnostic gap worldwide,” said director of Darpa’s office of biological technology to the Guardian, Dr. Brad Ringeisen, as it must also fill test gaps in the later stages of infection. If he got FDA approval, he said, it had the potential to be “absolutely a game changer.”
Last update: 08:05

© RESERVED REPRODUCTION



[ad_2]